Literature DB >> 26297544

MiR-548-3p functions as an anti-oncogenic regulator in breast cancer.

Yafei Shi1, Min Qiu1, Yanyan Wu1, Lu Hai2.   

Abstract

Emerging evidence has found that microRNAs (miRNA) play an important role in breast cancer. MiR-548 family has been demonstrated to be involved in the pathogenesis of several cancers. However, its role in breast cancer has not yet been elucidated. To explore this concern, we explored the expression of miR-548-3p in clinical specimens and breast cancer cells by qRT-PCR. In addition, an CCK-8 assay and Caspase 3/7 activity were used to evaluated the rates of cell proliferation and apoptosis. Protein expression was analyzed by western blotting and the target gene was confirmed using a luciferase reporter assay. Our results illustrated that miR-548-3p was significantly downregulated in breast cancer. Overexpression of miR-548-3p inhibited the proliferation and promoted the apoptosis of breast cancer cells. In addition, ECHS1 expression was demonstrated to be significantly upregulated in breast cancer tissues and cells, and the ECHS1 gene was identified to be one target of miR-548-3p. Therefore, our results demonstrated that miR-548-3p inhibited the proliferation of breast cancer cells by regulating the expression of ECHS1, indicating its potential as a therapeutic target for breast cancer.
Copyright © 2015. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Breast cancer; ECHS1; MiR-548-3p; MicroRNAs

Mesh:

Substances:

Year:  2015        PMID: 26297544     DOI: 10.1016/j.biopha.2015.07.027

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  23 in total

1.  MiR-548a-3p Promotes Keratinocyte Proliferation Targeting PPP3R1 after Being Induced by IL-22.

Authors:  Xintong Zhao; Ronghua Li; Meng Qiao; Jianjun Yan; Qing Sun
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

2.  MicroRNA analysis of breast ductal fluid in breast cancer patients.

Authors:  Luisa Matos Do Canto; Catalin Marian; Shawna Willey; Mary Sidawy; Patricia A Da Cunha; Janice D Rone; Xin Li; Yuriy Gusev; Bassem R Haddad
Journal:  Int J Oncol       Date:  2016-03-10       Impact factor: 5.650

3.  Maternal plasma miRNAs as biomarkers during mid-pregnancy to predict later spontaneous preterm birth: a pilot study.

Authors:  Clint Gray; Lesley M McCowan; Rachna Patel; Rennae S Taylor; Mark H Vickers
Journal:  Sci Rep       Date:  2017-04-11       Impact factor: 4.379

4.  Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas.

Authors:  Francesco Vasuri; Silvia Fittipaldi; Vanessa De Pace; Laura Gramantieri; Valentina Bertuzzo; Matteo Cescon; Antonio D Pinna; Michelangelo Fiorentino; Antonia D'Errico; Matteo Ravaioli
Journal:  Oncotarget       Date:  2018-04-03

5.  Relative miRNA and mRNA expression involved in arsenic methylation.

Authors:  Huirong Cheng; Pei Hu; Weihua Wen; Ling Liu
Journal:  PLoS One       Date:  2018-12-13       Impact factor: 3.240

6.  UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.

Authors:  Dan Jin; Jiwei Guo; Yan Wu; Jing Du; Xiaohong Wang; Jiajia An; Baoguang Hu; Lingqun Kong; Weihua Di; Wansheng Wang
Journal:  Theranostics       Date:  2019-03-17       Impact factor: 11.556

7.  miR-548d-3p inhibits osteosarcoma by downregulating KRAS.

Authors:  Jianhua Chen; Chongnan Yan; Honghao Yu; Shihan Zhen; Quan Yuan
Journal:  Aging (Albany NY)       Date:  2019-07-21       Impact factor: 5.682

8.  Ameloblastoma RNA profiling uncovers a distinct non-coding RNA signature.

Authors:  Haleh Davanian; Anangi Balasiddaiah; Robert Heymann; Magnus Sundström; Poppy Redenström; Mikael Silfverberg; David Brodin; Matti Sällberg; Sven Lindskog; Carina Kruger Weiner; Margaret Chen
Journal:  Oncotarget       Date:  2017-01-17

9.  CircRNA-associated ceRNA network reveals ErbB and Hippo signaling pathways in hypopharyngeal cancer.

Authors:  Chun Feng; Yuxiao Li; Yan Lin; Xianbao Cao; Dongdong Li; Honglei Zhang; Xiaoguang He
Journal:  Int J Mol Med       Date:  2018-10-19       Impact factor: 4.101

10.  Plasma extracellular vesicle‑packaged microRNAs as candidate diagnostic biomarkers for early‑stage breast cancer.

Authors:  Chen Yan; Jintao Hu; Yipeng Yang; Hong Hu; Dongxian Zhou; Min Ma; Nan Xu
Journal:  Mol Med Rep       Date:  2019-09-10       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.